Nuvation Bio falls after AnHeart Therapeutics acquisition news

Nuvation Bio falls after AnHeart Therapeutics acquisition news
1.5BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US67080N1019
CUSIP
67080N101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.88
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.43
Wall Street Target Price
12.33
EPS Estimate Current Year
-0.28
EPS Estimate Next Year
-0.06
EPS Estimate Current Quarter
0.05
EPS Estimate Next Quarter
-0.11
Most Recent Quarter
-
Revenue TTM
143,046,000
Gross Profit TTM
129,851,000
EBITDA
-148,214,000
Profit Margin
-102.06%
Return On Assets TTM
-17.02%
Return On Equity TTM
-39.51%
Revenue Per Share TTM
0.416
Qtly Revenue Growth YOY
2598.70%
Diluted Eps TTM
-0.43
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
10.248
Price Book MRQ
4.5873
Enterprise Value Revenue
6
Enterprise Value EBITDA
2
283.89
3.04%136.01
1.42%17.40
0.75%294.30
0.33%803.19
0.00%630.30
-11.57%434.31
-3.61%797.77
-2.91%147.30
-1.49%68.51
-0.71%